[Onset of neurological symptoms during tuberculosis treatment: description of two cases].
Arquinio
Luis
L
García-Gasalla
Mercedes
M
Losada
Inés
I
Sarasibar
Helena
H
D000328:Adult; D000369:Aged, 80 and over; D000995:Antitubercular Agents / Q000627:therapeutic use*; D001037:Aphasia / Q000209:etiology*; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D004421:Dystonia / Q000209:etiology*; D004977:Ethambutol / Q000008:administration & dosage / Q000627:therapeutic use; D005157:Facial Pain / Q000209:etiology*; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008297:Male; D009549:Nigeria / Q000208:ethnology; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D011718:Pyrazinamide / Q000008:administration & dosage / Q000627:therapeutic use; D012021:Reflex, Abnormal; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D014202:Tremor / Q000209:etiology*; D014375:Tuberculoma / Q000150:complications* / Q000473:pathology; D014390:Tuberculosis, Meningeal / Q000150:complications* / Q000188:drug therapy; D014391:Tuberculosis, Miliary / Q000150:complications* / Q000188:drug therapy
D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D011241:Prednisone; D012293:Rifampin